Cure Vac's m RNA vaccine for Zika virus
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:administered_by |
injection
|
| gptkbp:aims_to |
immune response against Zika virus
|
| gptkbp:developed_by |
response to Zika virus outbreaks
|
| https://www.w3.org/2000/01/rdf-schema#label |
Cure Vac's m RNA vaccine for Zika virus
|
| gptkbp:is_anticipated_by |
contribute to public health efforts
|
| gptkbp:is_based_on |
messenger RNA technology
|
| gptkbp:is_being_developed_alongside |
other m RNA vaccines
|
| gptkbp:is_designed_to |
long-lasting immunity
safe and effective prevent Zika virus infection |
| gptkbp:is_evaluated_by |
safety and immunogenicity
|
| gptkbp:is_expected_to |
reduce Zika virus transmission
|
| gptkbp:is_in |
clinical trials
|
| gptkbp:is_part_of |
global vaccine initiatives
Cure Vac's broader m RNA platform Cure Vac's vaccine pipeline a portfolio of infectious disease vaccines vaccine development efforts against emerging viruses |
| gptkbp:is_studied_for |
efficacy in humans
|
| gptkbp:targets |
Zika virus proteins
|
| gptkbp:bfsParent |
gptkb:Cure_Vac_AG
|
| gptkbp:bfsLayer |
5
|